News + Resources
What They Are Saying: Proposed Premerger Review Rules Would Burden Life Sciences Innovators, Impede Vital New Therapies
In a sharp departure from longstanding precedent, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have proposed substantial changes to the existing guidelines and rules for antitrust enforcement.
What They Are Saying: Proposed Merger Guidelines Would Stall Innovation, Slowing Treatments and Cures for Patients
In a sharp departure from longstanding precedent, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have proposed substantial changes to the existing guidelines and rules for antitrust enforcement.
Politico Op-ed: The Justice Department Controversy You Might Have Missed
In a recent op-ed for Politico, Ankush Khardori, an attorney and former federal prosecutor for the Department of Justice (DOJ), points out the noticeable lack of evidence behind the DOJ and Federal Trade Commissions’ (FTC) proposed merger guidelines.
Life Sciences Leaders, Advocates Launch New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions
Partnership for the U.S. Life Science Ecosystem to raise awareness on importance of mergers and acquisitions in advancing future cures and treatments WASHINGTON, D.C. – More than thirty leading organizations from across the life sciences today launched the...
Life Sciences Mergers and Acquisitions (M&A): Myths vs. Facts
Mergers and acquisitions (M&A) allow life sciences companies of all sizes to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients. Decades of pro-innovation policies have helped catalyze this…
Pro-Innovation Mergers & Acquisitions: Maintaining America’s Leadership in Biopharmaceutical Breakthroughs
Thousands of U.S. life sciences companies race every day to find better treatments and cures for a wide range of conditions and diseases. Within this diverse and dynamic life sciences ecosystem – made up of early-stage companies, large-scale entities, research...
The Pro-Competition Policies Driving Life Science Innovation
America has a long history of enacting sound, bipartisan policies that have created powerful incentives for life sciences innovators to invest in the costly, extensive research and development (R&D) process behind groundbreaking treatments and cures. These...